CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
The Efficacies and Safeties of a 0.05% Cyclosporine Nanoemulsion and a 0.1% Cyclosporine Cationic Emulsion
Man Ji, Chul Young Choi, Seong-Jae Kim, Jinho Jeong
J Korean Ophthalmol Soc. 2022;63(10):834-840.   Published online October 14, 2022
DOI: https://doi.org/10.3341/jkos.2022.63.10.834

Excel Download

The Efficacies and Safeties of a 0.05% Cyclosporine Nanoemulsion and a 0.1% Cyclosporine Cationic Emulsion
Journal of the Korean Ophthalmological Society. 2022;63(10):834-840   Crossref logo
Link1 Link2 Link3

Efficacy of Switching from Cyclosporine A 0.05% Anionic Emulsion to Cyclosporine A 0.1% Cationic Emulsion in Patients with Dry Eye Associated with Sjögren's Syndrome
Journal of Ocular Pharmacology and Therapeutics. 2021;37(8):472-478   Crossref logo
Link1 Link2

Contributing Factors Affecting Ocular Discomfort on Instillation and Compliance of 0.1% Cyclosporine A Cationic Nanoemulsion
Journal of the Korean Ophthalmological Society. 2021;62(4):429-438   Crossref logo
Link1 Link2 Link3

Efficacy of Topical Cyclosporine Nanoemulsion 0.05% Compared with Topical Cyclosporine Emulsion 0.05% and Diquafosol 3% in Dry Eye
Korean Journal of Ophthalmology. 2019;33(4):343   Crossref logo
Link1 Link2 Link3

<p>Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease</p>
Clinical Ophthalmology. 2020;Volume 14:2747-2755   Crossref logo
Link1 Link2

Concerns over Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease
European Journal of Ophthalmology. 2017;27(6):e193-e193   Crossref logo
Link1 Link2 Link3

A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis
Ophthalmology. 2019;126(5):671-681   Crossref logo
Link1 Link2

Topical cyclosporine A cationic ophthalmic emulsion in paediatric vernal keratoconjunctivitis: pooled analysis of randomised NOVATIVE and VEKTIS trials
Eye. 2022;   Crossref logo
Link1 Link2 Link3

Structure of Cyclosporine and Its Metabolites: Total Synthesis of Cyclosporine Metabolites Formed by Oxidation at Positions 4 and 9 of Cyclosporine. Preparation of Leucine-4-cyclosporine, (γ-Hydroxy)-N-methyl-leucine-9-cyclosporine and Leucine-4-(γ-hydroxy)-N-methyl-leucine-9-cyclosporine
CHIMIA. 1992;46(7-8):314   Crossref logo
Link1 Link2

Subgroup analysis of two phase III studies of 0.1% cyclosporine A cationic emulsion (CsA CE) in patients with dry eye disease
Acta Ophthalmologica. 2016;94:   Crossref logo
Link1 Link2